Palisade Bio, Inc. (PALI) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
PALI Revenue Growth
PALI Revenue Analysis (2014–2025)
As of May 8, 2026, Palisade Bio, Inc. (PALI) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue.
Looking at the longer-term picture, PALI's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $260,000 in 2018.
When compared to Healthcare sector peers including NKTR (-43.9% YoY), HALO (+37.6% YoY), and CHRS (-78.1% YoY). Compare PALI vs NKTR →
PALI Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| PALICurrent | $0 | - | - | - | |
 NKTR | $55M | -43.9% | -18.4% | -236.8% | |
 HALO | $1.4B | +37.6% | +39.2% | 58.4% | |
 CHRS | $42M | -78.1% | -38.4% | -429.5% | |
 PRTA | $10M | -58.0% | +62.6% | -1905.8% | |
 VNDA | $216M | +8.2% | -2.7% | -70.0% |
PALI Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-3,000 | - | $-18,056,000 | - |
| 2024 | $0 | -100.0% | $0 | - | $-14,859,000 | - |
| 2023 | $250K | - | $250K | 100.0% | $-13,070,000 | -5228.0% |
| 2022 | $0 | - | $0 | - | $-15,721,000 | - |
| 2021 | $0 | - | $0 | - | $-41,854,000 | - |
| 2020 | $0 | -100.0% | $-146,000 | - | $-9,297,000 | - |
| 2019 | $15K | -94.1% | $15K | 100.0% | $-8,632,000 | -56073.8% |
| 2018 | $260K | +0.0% | $1.3M | 480.8% | $-8,259,000 | -3176.5% |
| 2017 | $260K | +1500.4% | $260K | 100.0% | $-13,215,000 | -5082.7% |
| 2016 | $16K | +56.0% | $16K | 100.0% | $-20,167,000 | -124135.2% |
See PALI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PALI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PALI vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPALI — Frequently Asked Questions
Quick answers to the most common questions about buying PALI stock.
Is PALI's revenue growth accelerating or slowing?
PALI TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is PALI's long-term revenue growth rate?
Palisade Bio, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is PALI's revenue distributed by segment?
PALI reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.